Back to Search
Start Over
Combination of UHPLC-MS/MS-molecular networking approach and FTICR-MS for the metabolic profiling of Saccharomyces cerevisiae
- Source :
- Journal of Pharmaceutical and Biomedical Analysis, Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2021, 195, ⟨10.1016/j.jpba.2020.113857⟩
- Publication Year :
- 2021
- Publisher :
- HAL CCSD, 2021.
-
Abstract
- International audience; Natural products are a reliable source of bioactive molecules and represent an industrial and pharmaceu-tical stake. Indeed, the model yeast species Saccharomyces cerevisiae is a well-known eukaryotic organismlargely used as a biotechnological tool, but still a topical subject of study. In this work, the exploration ofSaccharomyces cerevisiae is taken further through an untargeted metabolomics workflow. The aim is toenrich databases and bring new information about the standard S. cerevisiae strain in a given medium.Analytical methods and bioinformatics tools were combined in a high-throughput methodology useableto dereplicate many types of biological extracts and cartography secondary metabolites. Ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) analyses were carriedout and spectral data were pre-processed to build molecular networks. Annotations were attributedto compounds through comparison with databases and manual investigation of networks. Ultra-high-resolution Fourier-transform ion cyclotron resonance mass spectrometry (FTICR-MS) brought additionalinformation thanks to a higher dynamic range and enhanced UHPLC-MS/MS results by unveiling ambi-guities and bringing accurate molecular formulae. Therefore, accurate and reliable annotated featuresresulted from the UHPLC-MS/MS data while FTICR-MS provided an overall cartography of metabolitesthanks to van Krevelen diagrams. Various small molecules such as amino acids derivatives and indolealkaloids have been determined for the first time in this yeast. The complementarity of FTICR-MS and UHPLC-MS/MS for secondary metabolite annotation brought this new mapping of S. cerevisiae.
- Subjects :
- FTICR-MS
Clinical Biochemistry
Saccharomyces cerevisiae
Pharmaceutical Science
Computational biology
Secondary metabolite
Mass spectrometry
01 natural sciences
Fourier transform ion cyclotron resonance
Analytical Chemistry
Metabolomics
Tandem Mass Spectrometry
[CHIM.ANAL]Chemical Sciences/Analytical chemistry
Drug Discovery
medicine
Molecular networking
Chromatography, High Pressure Liquid
Spectroscopy
Biological Products
biology
010405 organic chemistry
Chemistry
010401 analytical chemistry
biology.organism_classification
Dereplication
Small molecule
Yeast
0104 chemical sciences
[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 07317085
- Database :
- OpenAIRE
- Journal :
- Journal of Pharmaceutical and Biomedical Analysis, Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2021, 195, ⟨10.1016/j.jpba.2020.113857⟩
- Accession number :
- edsair.doi.dedup.....c5ef51de678cb0cfacb031ff7c6f7595
- Full Text :
- https://doi.org/10.1016/j.jpba.2020.113857⟩